F
2.96
-0.13 (-4.21%)
| Previous Close | 3.09 |
| Open | 3.09 |
| Volume | 89,918 |
| Avg. Volume (3M) | 6,532,995 |
| Market Cap | 34,404,080 |
| Price / Sales | 187.31 |
| Price / Book | 23.79 |
| 52 Weeks Range |
| Operating Margin (TTM) | -4,833.96% |
| Diluted EPS (TTM) | -1.60 |
| Quarterly Revenue Growth (YOY) | 178.90% |
| Current Ratio (MRQ) | 0.530 |
| Operating Cash Flow (TTM) | -6.16 M |
| Levered Free Cash Flow (TTM) | -2.49 M |
| Return on Assets (TTM) | -158.45% |
| Return on Equity (TTM) | -832.21% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Software - Application (US) | Bearish | Mixed |
| Software - Application (Global) | Bearish | Mixed | |
| Stock | Firefly Neuroscience, Inc. | - | - |
AIStockmoo Score
-1.0
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | -1.00 |
|
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. |
|
| Sector | Technology |
| Industry | Software - Application |
| % Held by Insiders | 42.31% |
| % Held by Institutions | 9.02% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Wexford Capital Lp | 31 Dec 2024 | 0 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Mar 2025 | Announcement | Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01 |
| 21 Feb 2025 | Announcement | Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million |
| 11 Feb 2025 | Announcement | Firefly Neuroscience Accepted into NVIDIA Connect Program |
| 07 Feb 2025 | Announcement | Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |